Daniel O’Connell, M.D., Ph.D.
Daniel O’Connell, M.D., Ph.D. has served as a member of LogicBio’s board of directors since June 2017. Dr. O’Connell currently serves as Executive Director, Corporate Development for Bristol Myers Squibb. Previously, he has served as an investment director at Arix Bioscience, a healthcare and life science company, from October 2016 to July 2019. Previously, Dr. O’Connell served as an associate at OrbiMed Advisors, a healthcare investment firm. He has served as a director of PreciThera, Inc., since July 2017. Dr. O’Connell holds an S.B. in both chemistry and mathematics from MIT and an M.D. and Ph.D. from Tufts University.